Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions

Clinical Chemistry

Volumn 58, Issue 2, 2012, Pages 458-464

  Ribichini, Flavio ^a   Gambaro, Giovanni ^b   Graziani, Maria Stella ^c   Pighi, Michele ^a   Pesarini, Gabriele ^a   Pasoli, Paolo ^a   Anselmi, Maurizio ^a   Ferrero, Valeria ^a   Yabarek, Tewoldemedhn ^a   Sorio, Alessandro ^c   Rizzotti, Paolo ^c   Lupo, Antonio ^a   Vassanelli, Corrado ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; CREATININE; CYSTATIN C;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; CREATININE; CYSTATIN C; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84856390844     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.170464     Document Type: Article

References (30)

1. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275:1489-94. (Pubitemid 26140761)
2. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393-9. (Pubitemid 39303939)
3. Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005;95:13-9. (Pubitemid 40051105)
4. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography.N Engl J Med 2003;348:491-9. (Pubitemid 36159884)
5. Briguori C, Colombo A, Airoldi F, Violante A, Castelli A, Balestrieri P, et al. N-acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2004;44:762-5. (Pubitemid 39099569)
6. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.
7. Kolonko A, Wiecek A. Contrast-associated nephropathy: old clinical problem and new therapeutic perspectives. Nephrol Dial Transplant 1998;13:803-6. (Pubitemid 28119084)
8. Nikolsky E, Mehran R, Turcot D, Aymong ED, Mintz GS, Lasic Z, et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 2004;94:300-5. (Pubitemid 38962693)
9. Nikolsky E, Mehran R, Lasic Z, Mintz GS, Lansky AJ, Na Y, et al. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 2005;67:706-13. (Pubitemid 40139864)
10. Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, et al. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol 2003;15:18-22. (Pubitemid 36143008)
11. Dalton RN. Serum creatinine and glomerular filtration rate: perception and reality. Clin Chem 2010;56:687-9.
12. Filler G, Bokenkamp A, Hoffman W, Le Bricon T, Martinez Bru C, Grubb A. Cystatin C as a marker of GFR: history, indication and future research. Clin Biochem 2005;38:1-8. (Pubitemid 39647648)
13. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049-60. (Pubitemid 40664306)
14. Kimmel M, Butscheid M, Brenner S, Kuhlmann U, Klotz U, Alscher DM. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc-preliminary results. Nephrol Dial Transplant 2008;23:1241-5. (Pubitemid 351767504)
15. Briguori C, Visconti G, Rivera NV, Focaccio A, Golia B, Giannone R, et al. Cystatin C and contrast-induced acute kidney injury. Circulation 2010;121:2117-22.
16. Rickli H, Benou K, Ammann P, Fehr T, Brunner-La Rocca HP, et al. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol 2004;61:98-102. (Pubitemid 38219904)
17. Kato K, Sato N, Yamamoto T, Iwasaki YK, Tanaka K, Mizuno K. Valuable markers for contrastinduced nephropathy in patients undergoing cardiac catheterization. Circ J 2008;72:1499-505.
18. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
19. Ribichini F, Graziani MS, Gambaro G, Pasoli P, Pighi M, Pesarini G, et al. Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. Am J Med 2010;123:755-63.
20. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-54. (Pubitemid 46768608)
21. Keevil BG, Kilpatrick ES, Nichols SP, Maylor PW. Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clin Chem 1998;44:1535-9. (Pubitemid 28309116)
22. Reinhard M, Erlandsen EJ, Randers E. Biological variation of cystatin C and creatinine. Scand J Clin Chem Lab Invest 2009;69:831-6.
23. Fraser CG. Data on biological variation: essential prerequisite for introducing new procedures. Clin Chem 1994;40:1671-3.
24. Ricòs C, Cava F, Garcia-Lario JV, Hernàndez A, Iglesias N, Jiménez CV, et al. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest 2004;64:175-84. (Pubitemid 38803101)
25. Ribichini F, Pesarini G, Gambaro G. Cystatin C and contrast-induced acute kidney injury. Circulation 2011;123:e225.
26. Spanaus K-S, Kollerits B, Ritz E, Hersberger M, Kronenberg F, von Eckardstein A. Serum creatinine, cystatin C, and β-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease. Clin Chem 2010;56:740-9.
27. Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, Lee HT. Association between increases in urinary neutrophil gelatinase-associated lipocalin (NGAL) and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006;105:485-91. (Pubitemid 44310430)
28. Han WK, Waikar SS, Johnson A, Betensky RA, Dent CL, Devarajen P, Bonventre JV. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int 2008;73:863-9. (Pubitemid 351398278)
29. Ling W, Zhaohuoi N, Ben H, Leyi G, Jianping L, Huili D, Jiaqi Q. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract 2008;108:176-81.
30. Waikar SS, Bonventre JV. Creatinine kinetics and the definition of acute kidney injury. J Am Soc Nephrol 2009;20:672-9.